Uhrig Markus M - OmicsDI

Show results for

Unknown (2)
Proteomics (2)
Transcriptomics (1)

Organisms

Aspergillus giganteus (2)
Meyerozyma guilliermondii (2)
Staphylococcus aureus subsp. aureus MRSA252 (2)
environmental samples (2)
Gallus (2)
Moringa oleifera (2)
Passer hispaniolensis (2)
Cynara cardunculus var. scolymus (2)
Passer domesticus domesticus (2)
Phytophthora nicotianae (2)
organismal metagenomes (2)
Lacticaseibacillus rhamnosus (2)
Limosilactobacillus reuteri (2)
Pseudomonas sp. M1 (2)
Leptospira biflexa serovar Patoc (2)
Fusarium sp. (2)
Gorilla (2)
Tetronarce californica (2)
Methanosarcina acetivorans (2)
Streptomyces mirabilis (2)
Lolium multiflorum (2)
Pseudomonas phage PaMx74 (2)
Penicillium sp. B12 (2)
Schizosaccharomyces pombe strain SPY73 975 h+ (2)
Euroleon nostras (2)
Cucumis melo (2)
Aspergillus puulaauensis (2)
Influenza A virus (A/Philippines/2/1982(H3N2)) (2)
Influenza A virus (A/New Caledonia/20/1999(H1N1)) (2)
Homo sapiens (1)

Repository

pride (2)
biostudies-arrayexpress (1)

Tissue

Blood plasma (1)

Disease

COVID-19 (1)

Technology Type

SWATH MS (2)
Mass Spectrometry (2)

Publication Date

2009 (1)
2022 (1)
2021 (1)

Study type

Transcription profiling by array (1)

Release Date

2025 (2)
2009 (1)

Lab affiliation

Charité – Universitätsmedizin Berlin, Department of Biochemistry, 10117 Berlin, Germany; The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, UK (2)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Transcription profiling of human neuroblastoma cell line SH-SY5Y transfected to produce phenotypes with low, medium or high levels of beta-amyloid peptides with 40 or 42 amino acids

Alzheimer's disease (AD) is characterized by massive neurodegeneration and multiple changes in cellular processes, including neurogenesis. Proteolytic processing of the amyloid precursor protein (APP) plays a central role in AD. Due to varying APP processing, several beta-amyloid peptides are genera...

ORGANISM(S): Homo sapiens

2009-06-01 | E-MEXP-1913 | biostudies-arrayexpress

The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study.

Not available

S-EPMC12178961 | biostudies-literature

A time-resolved proteomic and prognostic map of COVID-19

We performed quantitative proteomic profiling of 786 plasma samples from COVID-19 inpatients, treated at two different hospitals (Charité – Universitätsmedizin Berlin and University Hospital of Innsbruck). Sampling was performed at multiple time points throughout the course of the disease, to create...

ORGANISM(S): Homo sapiens (Human)

2021-07-19 | PXD025752 | Pride

A proteomic survival predictor for COVID-19 patients in intensive care

Global healthcare systems are challenged by the COVID-19 pandemic. There is a need to optimize allocation of treatment and resources in intensive care, as clinically established risk assessments such as SOFA and APACHE II scores show only limited performance for predicting the survival of severely i...